Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial

Fig. 1

Feasibility of plasma cell purification, iFISH, and gene expression profiling within the GMMG-MM5 trial. Percentages are given for feasibility of plasma cell purification (ALL) as well as performing of interphase fluorescence in situ hybridization (iFISH) and gene expression profiling (GEP) using DNA-microarrays. For the latter two, columns refer to both all patients and those for which purified plasma cells were available. BM(A), bone marrow (aspiration); na, not available

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us